|
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: RTRAF |
Gene summary for RTRAF |
| Gene information | Species | Human | Gene symbol | RTRAF | Gene ID | 51637 |
| Gene name | RNA transcription, translation and transport factor | |
| Gene Alias | C14orf166 | |
| Cytomap | 14q22.1 | |
| Gene Type | protein-coding | GO ID | GO:0000394 | UniProtAcc | Q549M8 |
Top |
Malignant transformation analysis |
Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
| Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
| 51637 | RTRAF | GSM4909281 | Human | Breast | IDC | 5.53e-03 | 3.06e-01 | 0.21 |
| 51637 | RTRAF | GSM4909282 | Human | Breast | IDC | 1.75e-19 | 6.14e-01 | -0.0288 |
| 51637 | RTRAF | GSM4909285 | Human | Breast | IDC | 7.28e-35 | 6.89e-01 | 0.21 |
| 51637 | RTRAF | GSM4909286 | Human | Breast | IDC | 7.48e-09 | 1.70e-01 | 0.1081 |
| 51637 | RTRAF | GSM4909287 | Human | Breast | IDC | 2.69e-07 | 3.38e-01 | 0.2057 |
| 51637 | RTRAF | GSM4909290 | Human | Breast | IDC | 1.31e-06 | 3.14e-01 | 0.2096 |
| 51637 | RTRAF | GSM4909293 | Human | Breast | IDC | 3.71e-11 | 2.77e-01 | 0.1581 |
| 51637 | RTRAF | GSM4909294 | Human | Breast | IDC | 5.56e-05 | 3.19e-01 | 0.2022 |
| 51637 | RTRAF | GSM4909296 | Human | Breast | IDC | 5.83e-03 | 1.90e-01 | 0.1524 |
| 51637 | RTRAF | GSM4909297 | Human | Breast | IDC | 1.49e-03 | 9.25e-02 | 0.1517 |
| 51637 | RTRAF | GSM4909298 | Human | Breast | IDC | 6.12e-03 | 2.21e-01 | 0.1551 |
| 51637 | RTRAF | GSM4909299 | Human | Breast | IDC | 3.79e-02 | 2.59e-01 | 0.035 |
| 51637 | RTRAF | GSM4909304 | Human | Breast | IDC | 6.11e-06 | 3.16e-01 | 0.1636 |
| 51637 | RTRAF | GSM4909305 | Human | Breast | IDC | 1.16e-14 | 3.46e-01 | 0.0436 |
| 51637 | RTRAF | GSM4909306 | Human | Breast | IDC | 7.14e-05 | 2.98e-01 | 0.1564 |
| 51637 | RTRAF | GSM4909308 | Human | Breast | IDC | 1.23e-23 | 5.16e-01 | 0.158 |
| 51637 | RTRAF | GSM4909311 | Human | Breast | IDC | 1.78e-16 | -2.47e-01 | 0.1534 |
| 51637 | RTRAF | GSM4909312 | Human | Breast | IDC | 5.51e-03 | 3.68e-04 | 0.1552 |
| 51637 | RTRAF | GSM4909315 | Human | Breast | IDC | 4.91e-09 | 5.16e-01 | 0.21 |
| 51637 | RTRAF | GSM4909316 | Human | Breast | IDC | 2.38e-08 | 6.08e-01 | 0.21 |
| Page: 1 2 3 4 5 6 7 8 9 |
| ∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
| Tissue | Disease Stage | Enriched GO biological Processes |
| Colorectum | AD | ![]() |
| Colorectum | SER | ![]() |
| Colorectum | MSS | ![]() |
| Colorectum | MSI-H | ![]() |
| Colorectum | FAP | ![]() |
| ∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
| Page: 1 2 3 4 5 6 7 8 9 |
| GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
| GO:000193321 | Stomach | CSG | negative regulation of protein phosphorylation | 32/1034 | 342/18723 | 2.56e-03 | 2.49e-02 | 32 |
| GO:004232621 | Stomach | CSG | negative regulation of phosphorylation | 35/1034 | 385/18723 | 2.68e-03 | 2.57e-02 | 35 |
| GO:0008380113 | Thyroid | PTC | RNA splicing | 273/5968 | 434/18723 | 4.44e-41 | 1.40e-37 | 273 |
| GO:0006403112 | Thyroid | PTC | RNA localization | 130/5968 | 201/18723 | 9.23e-22 | 1.94e-19 | 130 |
| GO:003447018 | Thyroid | PTC | ncRNA processing | 215/5968 | 395/18723 | 7.14e-21 | 1.22e-18 | 215 |
| GO:00346608 | Thyroid | PTC | ncRNA metabolic process | 239/5968 | 485/18723 | 5.54e-16 | 4.26e-14 | 239 |
| GO:0010563113 | Thyroid | PTC | negative regulation of phosphorus metabolic process | 219/5968 | 442/18723 | 4.47e-15 | 3.07e-13 | 219 |
| GO:0045936113 | Thyroid | PTC | negative regulation of phosphate metabolic process | 218/5968 | 441/18723 | 7.08e-15 | 4.75e-13 | 218 |
| GO:0051236110 | Thyroid | PTC | establishment of RNA localization | 100/5968 | 166/18723 | 4.26e-14 | 2.58e-12 | 100 |
| GO:0050657110 | Thyroid | PTC | nucleic acid transport | 98/5968 | 163/18723 | 9.08e-14 | 4.90e-12 | 98 |
| GO:0050658110 | Thyroid | PTC | RNA transport | 98/5968 | 163/18723 | 9.08e-14 | 4.90e-12 | 98 |
| GO:0001933113 | Thyroid | PTC | negative regulation of protein phosphorylation | 173/5968 | 342/18723 | 3.46e-13 | 1.75e-11 | 173 |
| GO:0042326113 | Thyroid | PTC | negative regulation of phosphorylation | 189/5968 | 385/18723 | 1.00e-12 | 4.64e-11 | 189 |
| GO:0015931110 | Thyroid | PTC | nucleobase-containing compound transport | 120/5968 | 222/18723 | 5.45e-12 | 2.35e-10 | 120 |
| GO:0051348113 | Thyroid | PTC | negative regulation of transferase activity | 137/5968 | 268/18723 | 3.78e-11 | 1.36e-09 | 137 |
| GO:0006469111 | Thyroid | PTC | negative regulation of protein kinase activity | 107/5968 | 212/18723 | 1.24e-08 | 2.96e-07 | 107 |
| GO:0033673111 | Thyroid | PTC | negative regulation of kinase activity | 115/5968 | 237/18723 | 5.98e-08 | 1.26e-06 | 115 |
| GO:000838029 | Thyroid | goiters | RNA splicing | 31/497 | 434/18723 | 6.49e-07 | 3.95e-05 | 31 |
| GO:003447019 | Thyroid | goiters | ncRNA processing | 28/497 | 395/18723 | 2.63e-06 | 1.30e-04 | 28 |
| GO:003466014 | Thyroid | goiters | ncRNA metabolic process | 29/497 | 485/18723 | 4.41e-05 | 1.53e-03 | 29 |
| Page: 1 2 3 4 5 6 7 8 9 10 11 12 |
| Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
| Page: 1 |
Top |
Cell-cell communication analysis |
Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
| Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
| Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
| TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
| ∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
| Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
Annotation of somatic variants for genes involved in malignant transformation |
| Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
| Page: 1 |
Top |
Related drugs of malignant transformation related genes |
Identification of chemicals and drugs interact with genes involved in malignant transfromation |
| (DGIdb 4.0) |
| Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
| Page: 1 |